Kenneth J. Kelley, Director at HALOZYME THERAPEUTICS INC (HALO), sold 22,300 shares at $10.24 ($229K) on 2007-05-25, disclosed to the SEC on 2007-05-25.
Open-market sale of $229k HALO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.20 | 100 | $1K | 0.4% |
| 2 | $10.21 | 1,100 | $11K | 4.9% |
| 3 | $10.22 | 1,000 | $10K | 4.5% |
| 4 | $10.23 | 1,100 | $11K | 4.9% |
| 5 | $10.24 | 700 | $7K | 3.1% |
| 6 | $10.24 | 100 |
| $1K |
| 0.4% |
| 7 | $10.25 | 5,562 | $57K | 24.9% |
| 8 | $10.25 | 100 | $1K | 0.4% |
| 9 | $10.26 | 3,000 | $31K | 13.4% |
| 10 | $10.26 | 300 | $3K | 1.3% |
| 11 | $10.26 | 200 | $2K | 0.9% |
| 12 | $10.27 | 1,500 | $15K | 6.7% |
| 13 | $10.27 | 100 | $1K | 0.4% |
| 14 | $10.28 | 100 | $1K | 0.4% |
| 15 | $10.28 | 1,200 | $12K | 5.4% |
| 16 | $10.29 | 100 | $1K | 0.4% |
| 17 | $10.29 | 2,900 | $30K | 13.0% |
| 18 | $10.30 | 1,438 | $15K | 6.5% |
| 19 | $10.30 | 200 | $2K | 0.9% |
| 20 | $10.31 | 100 | $1K | 0.5% |
| 21 | $10.32 | 600 | $6K | 2.7% |
| 22 | $10.33 | 500 | $5K | 2.3% |
| 23 | $10.36 | 300 | $3K | 1.4% |
| Total | $10.26 avg | 22,300 | $229K | 100% |
| Filing → |
| HALO | SELL | 2021-02-01 | $469K | — | Filing → |
| HALO | SELL | 2021-01-04 | $417K | — | Filing → |
| HALO | SELL | 2020-12-07 | $1.4M | — | Filing → |